Bristol Myers Squibb Co
BMY· NYSE
Bristol Myers Squibb Co
- Last sale
- Oct 1, 2026 · -1.55%
- Market cap
- $125.55B
- 2.04B shares
- Filings
- 1,057
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $48,194,000,000 | reported | |
| FY 2024 | 2024-12-31 | $48,300,000,000 | reported | |
| FY 2023 | 2023-12-31 | $45,006,000,000 | reported | |
| FY 2022 | 2022-12-31 | $46,159,000,000 | reported | |
| FY 2021 | 2021-12-31 | $46,385,000,000 | reported | |
| FY 2020 | 2020-12-31 | $42,518,000,000 | reported | |
| FY 2019 | 2019-12-31 | $26,145,000,000 | reported | |
| FY 2018 | 2018-12-31 | $22,561,000,000 | reported | |
| FY 2017 | 2017-12-31 | $20,776,000,000 | reported | |
| FY 2016 | 2016-12-31 | $19,427,000,000 | reported | |
| FY 2015 | 2015-12-31 | $16,560,000,000 | reported | |
| FY 2014 | 2014-12-31 | $15,879,000,000 | reported |
Bristol Myers Squibb Co · CIK 14272 · Engraved from SEC EDGAR
